Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 13/20 | 0.47 |
| ▸ | GBA1 | P04062 | 1/20 | 0.42 |
| ▸ | RIOK2 | Q9BVS4 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CRHBP | P24387 | 1/20 | 0.38 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL272970 | 1.00 | KCNH2 (0.47) | KCNH2GBA1RIOK2ALDH1A1KDM4E | |
| SCHEMBL29397508 | 1.00 | KCNH2 (0.47) | KCNH2GBA1RIOK2ALDH1A1KDM4E | |
| SCHEMBL29397420 | 1.00 | KCNH2 (0.47) | KCNH2GBA1RIOK2ALDH1A1KDM4E | |
| SCHEMBL8206882 | 0.99 | KCNH2 (0.46) | KCNH2GBA1RIOK2ALDH1A1KDM4E | |
| Bromide SCHEMBL30705401 | 0.99 | KCNH2 (0.48) | KCNH2GBA1RIOK2ALDH1A1KDM4E | |
| SCHEMBL28025013 | 0.89 | KCNH2 (0.44) | KCNH2RIOK2ALDH1A1KDM4EMAPK1 | |
| SCHEMBL4343601 | 0.86 | KCNH2 (0.64) | KCNH2RIOK2ALDH1A1NPC1SMN1; SMN2 | |
| SCHEMBL4343598 | 0.86 | KCNH2 (0.64) | KCNH2RIOK2ALDH1A1NPC1SMN1; SMN2 | |
| SCHEMBL8654656 | 0.85 | KCNH2 (0.47) | KCNH2RIOK2ALDH1A1KDM4EMAPK1 | |
| SCHEMBL8654659 | 0.85 | KCNH2 (0.47) | KCNH2RIOK2ALDH1A1KDM4EMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025042635-A2 | COMPOSITIONS AND METHODS FOR COLORIMETRIC DETECTION OF TARGET PARTICLES | CODEAC SOLUTIONS, INC. (US) | 2025-02-27 | — | — | WO | claimed |
| US-20240118214-A1 | Colorimetric Detection of Actinides | US ENERGY (US) | 2024-04-11 | — | — | US | claimed |
| CN-110132957-B | General presentation method for common metal imprinting on surface of human skin | 中国人民公安大学 | 2024-01-26 | — | — | CN | claimed |
| CN-114152582-A | Method for analyzing uranium by using absolute ethyl alcohol-aqueous medium | 中核通辽铀业有限责任公司 | 2022-03-08 | — | — | CN | claimed |
| US-20210396680-A1 | COLORIMETRIC DETECTION OF ACTINIDES | UNITED STATES DEPARTMENT OF ENERGY | 2021-12-23 | — | — | US | claimed |
| CN-113143262-A | Latent fingerprint display and fixing method | 中国刑事警察学院 | 2021-07-23 | — | — | CN | claimed |
| CN-109456260-B | 2- (5-bromo-2-pyridylazo) -5-diethylaminophenol derivative, and preparation method and application thereof | 南华大学 | 2021-07-06 | — | — | CN | claimed |
| US-20200400583-A1 | Colorimetric Detection of Actinides | U.S. DEPARTMENT OF ENERGY | 2020-12-24 | — | — | US | claimed |
| US-9267188-B2 | Method for extraction and separation of lanthanoid elements and actinoid elements, and means for extraction and separation of lanthanoid elements and actinoid elements | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2016-02-23 | — | — | US | claimed |
| US-20110020943-A1 | DRY TESTING TOOL, METHOD FOR MEASURING METAL, AND METHOD FOR PRODUCING DRY TESTING TOOL | ARKRAY, INC. (JP) | 2011-01-27 | — | — | US | claimed |
| EP-2261656-A1 | DRY TEST INSTRUMENT, METHOD OF MEASURING METAL AND METHOD OF PRODUCING DRY TEST INSTRUMENT | ARKRAY, Inc. (JP) | 2010-12-15 | — | — | EP | claimed |
| CN-101024164-A | Column-filling and concentrated column for analyzing metal elements | UNIV SICHUAN (CN) | 2007-08-29 | — | — | CN | claimed |
| US-6107098-A | MIXTURE OF SODIUM CITRATE AND ETHYLENEDIAMINETETRAACETIC ACID AS METAL MASKING AGENTS, ALKALINE BUFFER, SOLUBILIZING AGENT, AND 2-(5-BROMO-S-PYRIDYLAZO)-5-DIETHYLAMINOPHENOL DYE WHICH COMPLEXES WITH URANIUM; RAPID, ACCURATE TEST FOR BATTLEFIELDS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 2000-08-22 | — | — | US | claimed |
| WO-2025230787-A3 | COMPOSITIONS AND METHODS FOR COLORIMETRIC DETECTION OF TARGET PARTICLES | COLOR TECH HOLDINGS, INC. (US) | 2026-01-08 | — | — | WO | disclosed |
| WO-2025230787-A2 | COMPOSITIONS AND METHODS FOR COLORIMETRIC DETECTION OF TARGET PARTICLES | COLOR TECH HOLDINGS, INC. (US) | 2025-11-06 | — | — | WO | disclosed |
| EP-3965738-B1 | METHOD FOR PRODUCTION OF LIPOSOMES | UNIV DO MINHO (PT) | 2025-08-06 | — | — | EP | disclosed |
| US-20030138374-A1 | Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same | BF RESEARCH INSTITUTE, INC. (JP) | 2003-07-24 | — | — | US | disclosed |
| EP-1266884-A1 | IMAGE DIAGNOSIS PROBE BASED ON SUBSTITUTED AZOBENZENE OR ANALOGUE THEREOF FOR DISEASE ATTRIBUTABLE TO AMYLOID ACCUMULATION AND COMPOSITION FOR IMAGE DIAGNOSIS CONTAINING THE SAME | BF Research Institute, Inc. (JP) | 2002-12-18 | — | — | EP | disclosed |
| US-6107098-A | MIXTURE OF SODIUM CITRATE AND ETHYLENEDIAMINETETRAACETIC ACID AS METAL MASKING AGENTS, ALKALINE BUFFER, SOLUBILIZING AGENT, AND 2-(5-BROMO-S-PYRIDYLAZO)-5-DIETHYLAMINOPHENOL DYE WHICH COMPLEXES WITH URANIUM; RAPID, ACCURATE TEST FOR BATTLEFIELDS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 2000-08-22 | — | — | US | disclosed |
| US-5925570-A | ADDING ADDITIONAL METAL SELECTED TO RELEASE METAL BOUND TO INTERFERING SUBSTANCES IN SAMPLE, ADDING COLOR-PRODUCING SUBSTANCE, SPECTROSCOPICALLY DETECTING SIGNAL | IATRON LABORATORIES, INC. (JP) | 1999-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030138374-A1 | Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same | APBA1, S100B, APP | KCNH2 870/4885GBA1 167/4885RIOK2 4354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.